TFF Pharmaceuticals to Present at the SNN Virtual Investor Conference on August 19, 2021
August 05, 2021 08:30 ET
|
TFF Pharmaceuticals, Inc.
AUSTIN, Texas, Aug. 05, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021
August 04, 2021 09:00 ET
|
TFF Pharmaceuticals, Inc.
AUSTIN, Texas, Aug. 04, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
Augmenta Bioworks and TFF Pharmaceuticals Announce Positive In Vitro Data Demonstrating Binding and Neutralization of the SARS-CoV-2 Delta Variant by Lead Anti-COVID-19 Antibody, AUG-3387
July 29, 2021 08:00 ET
|
TFF Pharmaceuticals, Inc.
Data Shows AUG-3387 Neutralizes SARS-CoV-2 Delta Variant in Infective Assays Supports Earlier Data Showing AUG-3387 Binds Strongly to Delta Variant in Addition to Wild-Type Spike Protein and Other...
TFF Pharmaceuticals to Participate in the BTIG Virtual Biotechnology Conference
July 28, 2021 08:00 ET
|
TFF Pharmaceuticals, Inc.
AUSTIN, Texas, July 28, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its Phase 1 Clinical Trial of Tacrolimus Inhalation Powder
July 13, 2021 08:00 ET
|
TFF Pharmaceuticals, Inc.
Inhaled Tacrolimus Powder Achieves Systemic Therapeutic Drug Levels Anticipate Additional Safety Data in 3Q 2021 Initiation of Lung Transplant Study Expected in 2H 2021 AUSTIN, Texas, July 13, 2021 ...
Augmenta Bioworks and TFF Pharmaceuticals Announce Selection of Lead Monoclonal Antibody Candidate AUG-3387 for Clinical Development Against COVID-19
June 22, 2021 08:00 ET
|
TFF Pharmaceuticals, Inc.
MENLO PARK, Calif. and AUSTIN, Texas, June 22, 2021 (GLOBE NEWSWIRE) -- Augmenta Bioworks, a biotechnology company enabling breakthroughs in medicine through immune profiling, and TFF...
TFF Pharmaceuticals Hosting Key Opinion Leader Perspectives on Thin Film Freezing Applications
June 07, 2021 08:00 ET
|
TFF Pharmaceuticals, Inc.
Focus on TFF Tacrolimus for Lung Transplant and TFF in Vaccine Technology Tuesday, June 15th @ 4pm ET AUSTIN, Texas, June 07, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a...
TFF Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
May 25, 2021 17:09 ET
|
TFF Pharmaceuticals, Inc.
AUSTIN, Texas, May 25, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...